Literature DB >> 21977375

Prevalence of metabolic syndrome in a predominantly cuban, psychiatrically ill, and homeless population.

Rafael A Rivas-Vazquez1, Iruma Bello, Manual Sarria, Noel D Fernandez, Gustavo J Rey.   

Abstract

OBJECTIVE: This study examined the prevalence of metabolic syndrome among a group of psychiatric outpatients enrolled in a homeless program that is located in a predominantly Hispanic geographic area of South Florida.
METHOD: Data for this retrospective, cross-sectional analysis were obtained from a record review of 122 adult patients who received full medical and psychiatric assessments based on DSM-IV criteria during participation in our homeless program from January 2009 to May 2009. The primary outcome measure was the presence of metabolic syndrome.
RESULTS: The prevalence of metabolic syndrome within this population was 29.5%. Elevated waist circumference (48.5%) and elevated blood pressure (44.3%) were the 2 most frequent risk factors for the syndrome. Mean length of homelessness was 3.93 years, with no significant relationship noted between the presence of metabolic syndrome and duration of homelessness. Ninety-three percent of the subjects had been diagnosed with either schizophrenia or a mood disorder, and 61% had been treated with an atypical antipsychotic for at least 2 months over the preceding year. Our sample was predominantly Hispanic (79.5%), with Cuban Americans comprising 95% of that group. Among Hispanics, the prevalence rate of metabolic syndrome was 28.9%.
CONCLUSIONS: Within our sample, homeless individuals compared to the general adult population in the United States seem to be at equal risk for metabolic syndrome. Although other studies have suggested an increased prevalence for metabolic syndrome among Hispanics, the obtained rate for our particular Hispanic sample was consistent with estimated prevalence of non-Hispanic individuals in the United States. Intervention programs rendering services to this population should include routine screening for presence of cardiovascular risk factors constituting metabolic syndrome.

Entities:  

Year:  2011        PMID: 21977375      PMCID: PMC3184567          DOI: 10.4088/PCC.10m01002

Source DB:  PubMed          Journal:  Prim Care Companion CNS Disord        ISSN: 2155-7780


  15 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

Review 2.  Consensus development conference on antipsychotic drugs and obesity and diabetes.

Authors: 
Journal:  Diabetes Care       Date:  2004-02       Impact factor: 19.112

3.  Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003-2006.

Authors:  R Bethene Ervin
Journal:  Natl Health Stat Report       Date:  2009-05-05

4.  Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians.

Authors:  Andrea Fagiolini; Ellen Frank; John A Scott; Scott Turkin; David J Kupfer
Journal:  Bipolar Disord       Date:  2005-10       Impact factor: 6.744

5.  Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey.

Authors:  Earl S Ford; Wayne H Giles; William H Dietz
Journal:  JAMA       Date:  2002-01-16       Impact factor: 56.272

6.  Risk factors for cardiovascular disease in homeless adults.

Authors:  Tony C Lee; John G Hanlon; Jessica Ben-David; Gillian L Booth; Warren J Cantor; Philip W Connelly; Stephen W Hwang
Journal:  Circulation       Date:  2005-05-16       Impact factor: 29.690

Review 7.  Premature mortality from general medical illnesses among persons with bipolar disorder: a review.

Authors:  Babak Roshanaei-Moghaddam; Wayne Katon
Journal:  Psychiatr Serv       Date:  2009-02       Impact factor: 3.084

8.  Metabolic syndrome in patients with schizophrenia.

Authors:  Tuula Heiskanen; Leo Niskanen; Riitta Lyytikäinen; Pirjo I Saarinen; Jukka Hintikka
Journal:  J Clin Psychiatry       Date:  2003-05       Impact factor: 4.384

Review 9.  A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?

Authors:  Sukanta Saha; David Chant; John McGrath
Journal:  Arch Gen Psychiatry       Date:  2007-10

10.  The moderating impact of ethnicity on metabolic outcomes during treatment with olanzapine and aripiprazole in patients with schizophrenia.

Authors:  Jonathan M Meyer; Lisa C Rosenblatt; Edward Kim; Ross A Baker; Richard Whitehead
Journal:  J Clin Psychiatry       Date:  2008-12-16       Impact factor: 4.384

View more
  3 in total

1.  Prevalence of cardiovascular risk factors among racial and ethnic minorities with schizophrenia spectrum and bipolar disorders: a critical literature review.

Authors:  Hannah Carliner; Pamela Y Collins; Leopoldo J Cabassa; Ann McNallen; Sarah S Joestl; Roberto Lewis-Fernández
Journal:  Compr Psychiatry       Date:  2013-10-22       Impact factor: 3.735

2.  Prevalence and Risk Factors of Metabolic Syndrome among the Homeless in Taipei City: A Cross-Sectional Study.

Authors:  Ming Gu; Chi-Jie Lu; Tian-Shyug Lee; Mingchih Chen; Chih-Kuang Liu; Ching-Lin Chen
Journal:  Int J Environ Res Public Health       Date:  2021-02-10       Impact factor: 3.390

Review 3.  Metabolic syndrome in schizophrenia.

Authors:  Nidhi Malhotra; Sandeep Grover; Subho Chakrabarti; Parmanand Kulhara
Journal:  Indian J Psychol Med       Date:  2013-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.